| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/29/2011 | US20110236480 Prebiotic formulations and methods of use |
| 09/29/2011 | US20110236479 Direct compression formulation and process |
| 09/29/2011 | US20110236478 Co-crystals and pharmaceutical formulations comprising the same |
| 09/29/2011 | US20110236477 Pharmaceutical composition, pharmaceutical dosage form, process for their preparation, methods for treating and uses thereof |
| 09/29/2011 | US20110236476 Pharmaceutical composition comprising eicosapentaenoic acid and nicotinic acid and methods of using same |
| 09/29/2011 | US20110236475 Granular pharmaceutical compositions |
| 09/29/2011 | US20110236474 Pharmaceutical Compositions of Selective Factor Xa Inhibitors for Oral Administration |
| 09/29/2011 | US20110236473 Stable aliskiren formulations |
| 09/29/2011 | US20110236472 Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance |
| 09/29/2011 | US20110236471 Platinum complexes and methods for inhibiting tumor cell proliferation |
| 09/29/2011 | US20110236470 GLUTAMYL tRNA SYNTHETASE (GtS) FRAGMENTS |
| 09/29/2011 | US20110236469 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 09/29/2011 | US20110236468 Vaccine compositions |
| 09/29/2011 | US20110236467 Method for erectile function potentiation by pharmaceutical compositions comprising toxin tx2-6 of the spider phoneutria nigriventer |
| 09/29/2011 | US20110236466 Chemo vector therapy to deliver chemotherapy molecules to specific cells to manage breast cancer, other cancers and inflammatory disorders |
| 09/29/2011 | US20110236465 Melt-extruded film |
| 09/29/2011 | US20110236464 Membrane |
| 09/29/2011 | US20110236463 Formulations for systemic buccal delivery comprising s-adenosylmethionine, their preparation and use |
| 09/29/2011 | US20110236462 Intravaginal drug delivery device |
| 09/29/2011 | US20110236461 Methods for stimulating chondrogenesis utilizing a potassium channel inhibitor |
| 09/29/2011 | US20110236460 Therapeutic Implant |
| 09/29/2011 | US20110236459 Therapeutic Implant |
| 09/29/2011 | US20110236457 Micronized Device for the Delivery of Biologically Active Molecules and Methods of Use Thereof |
| 09/29/2011 | US20110236454 Injectable drug delivery formulation |
| 09/29/2011 | US20110236443 Multilayer melt-extruded film |
| 09/29/2011 | US20110236441 Antimicrobial substrates and uses thereof |
| 09/29/2011 | US20110236440 Medical tape preparation |
| 09/29/2011 | US20110236439 Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexane |
| 09/29/2011 | US20110236438 Method of treatment of diseases using hoodia extracts |
| 09/29/2011 | US20110236437 Nanoparticles and methods of use |
| 09/29/2011 | US20110236436 Pharmaceutical composition for modified release |
| 09/29/2011 | US20110236435 ENHANCED BONE CELLS GROWTH AND PROLIFERATION ON TiO2 NANOTUBULAR SUBSTRATES TREATED BY RADIO-FREQUENCY PLASMA DISCHARGE |
| 09/29/2011 | US20110236434 Polymorphic Forms of ST-246 and Methods of Preparation |
| 09/29/2011 | US20110236433 Wound care device |
| 09/29/2011 | US20110236432 Coated Medical Device and Method of Coating a Medical Device to Reduce Fibrosis and Capsule Formation |
| 09/29/2011 | US20110236431 Treatment of acute myocardial infarction (ami) using encapsulated cells encoding and secreting glp-1 peptides or analogs thereof |
| 09/29/2011 | US20110236430 Method for controlling toxicity of metallic particle and low-toxicity composite of metallic nanoparticle and inorganic clay |
| 09/29/2011 | US20110236322 Oral ph and buffering capacity modifiers |
| 09/29/2011 | US20110236321 Aerosol Foams Comprising Clindamycin Phosphate |
| 09/29/2011 | US20110236320 Ultrasound Contrast Agents And Process For The Preparation Thereof |
| 09/29/2011 | US20110232650 Articles of clothing comprising ammonia oxidizing bacteria to increase production of nitric oxide and nitric oxide precursors |
| 09/29/2011 | DE19724456B4 Medizinische Mischungszusammensetzung mit lang anhaltender Arzneimittelabgabemöglichkeit Medical mixture composition with sustained drug delivery option |
| 09/29/2011 | DE102010012845A1 Durch Rotationsspinnverfahren hergestellte Mehrkomponentenfasern Produced by rotary spinning multicomponent fibers |
| 09/29/2011 | CA2831265A1 Composition for enhancing athletic performance |
| 09/29/2011 | CA2794540A1 Methods and compositions for weight loss |
| 09/29/2011 | CA2794503A1 Aerosol foams comprising clindamycin phosphate |
| 09/29/2011 | CA2794237A1 Novel composition for treatment of essential thrombocythemia |
| 09/29/2011 | CA2794221A1 Double-layer pharmaceutical formulations containing opioid agonists and antagonists |
| 09/29/2011 | CA2794195A1 Emulsions for microencapsulation comprising biodegradable surface-active block copolymers as stabilizers |
| 09/29/2011 | CA2794171A1 Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances |
| 09/29/2011 | CA2793973A1 Pharmaceutical compositions of carvedilol salts and process for preparation thereof |
| 09/29/2011 | CA2793536A1 Methods of treatment of hepatocellular carcinoma |
| 09/29/2011 | CA2793241A1 Method for preparing nano-particles |
| 09/29/2011 | CA2793089A1 Process of treatment of fibers and/or textile materials |
| 09/29/2011 | CA2792649A1 Improved methods and compositions for safe and effective treatment of telangiectasia |
| 09/29/2011 | CA2792646A1 Improved uses and compositions for safe and effective treatment of erythema |
| 09/29/2011 | CA2792470A1 Transdermal administration of peptides |
| 09/29/2011 | CA2792330A1 Nanoemulsion including sucrose fatty acid ester |
| 09/29/2011 | CA2792137A1 Reverse micelle system comprising nucleic acids and use thereof |
| 09/29/2011 | CA2792136A1 Reverse micelle system comprising metal ions and use thereof |
| 09/29/2011 | CA2789075A1 Solid preparation |
| 09/29/2011 | CA2789065A1 Solid preparation |
| 09/28/2011 | EP2368899A1 Avian influenza vaccine |
| 09/28/2011 | EP2368627A1 Method for producing liposome and method for dissolving cholesterol |
| 09/28/2011 | EP2368576A2 Functionally reconstituted viral membranes containing adjuvant |
| 09/28/2011 | EP2368575A2 Dry formulation for transcutaneous immunization |
| 09/28/2011 | EP2368565A1 Enrichment of pre-beta high density lipoproteins |
| 09/28/2011 | EP2368556A1 An osmotic drug delivery system |
| 09/28/2011 | EP2368554A1 Pharmaceutical formulations containing methylnaltrexone |
| 09/28/2011 | EP2368553A1 Pharmaceutical formulations containing methylnaltrexone |
| 09/28/2011 | EP2368548A1 Dry powder pharmaceutical composition for inhalation |
| 09/28/2011 | EP2368546A2 Pharmaceutical composition for the controlled release of methylphenidate |
| 09/28/2011 | EP2368545A1 Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof |
| 09/28/2011 | EP2368544A1 Orally rapidly disintegrating tablet, and process for producing same |
| 09/28/2011 | EP2368543A1 Method of preparing a granulated pharmaceutical composition comprising simvastatin and/or ezetimibe |
| 09/28/2011 | EP2368445A1 Stable Emulsions of Oils in Aqueous Solutions and Methods for Producing Same |
| 09/28/2011 | EP2368145A1 Ophthalmic devices for delivery of hydrophobic comfort agents |
| 09/28/2011 | EP2367682A1 Coating compositions and coated substrates for articles of manufacture used in contact with human body surfaces |
| 09/28/2011 | EP2367552A1 Silica-based antibacterial and antifungal nanoformulation |
| 09/28/2011 | EP2367542A1 Oral dosage forms of bendamustine |
| 09/28/2011 | EP2367541A1 Misuse preventative, controlled release formulation |
| 09/28/2011 | EP2367540A1 Oral dispersible tablet |
| 09/28/2011 | EP2367539A1 Novel composition for treatment of essential thrombocythemia |
| 09/28/2011 | EP2367538A2 Solid dosage forms of bendamustine |
| 09/28/2011 | EP2367537A1 Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same |
| 09/28/2011 | EP2367536A1 Controlled release pharmaceutical compositions comprising o-desmethyl-venlafaxine |
| 09/28/2011 | EP2367535A2 Pancreatic tumour treatment |
| 09/28/2011 | EP2367534A2 Pharmaceutical compositions containing inulin as granulation carrier |
| 09/28/2011 | EP2367533A1 Solid composition containing the ingredient rasagiline |
| 09/28/2011 | EP2367532A2 Method of making small liposomes |
| 09/28/2011 | EP2367531A1 Perfluorocarbon gel formulations |
| 09/28/2011 | EP2367530A2 Solutions for volume therapy |
| 09/28/2011 | EP2367529A1 Composition for the use to treat alzheimer' s disease |
| 09/28/2011 | EP2367528A1 Compositions of topical ocular solutions to deliver effective concentrations of active agent to the posterior segment of the eye |
| 09/28/2011 | EP2367527A2 Implantable ocular drug delivery device and methods |
| 09/28/2011 | EP2367526A1 Compositions and methods for alleviating hyposalivation and for providing oral comfort |
| 09/28/2011 | EP2367422A1 Enema formulations |
| 09/28/2011 | EP2367421A1 Oral formulations |
| 09/28/2011 | EP2033934B1 Hollow-fiber-like organic nanotube and process for production thereof |
| 09/28/2011 | EP1951314B1 Drug-delivery systems |